Lysine derivative histone deacetylase inhibitor, synthesis and application
A technology of lysine derivatives and deacetylase, which is applied in drug combination, thioether preparation, organic chemistry, etc., can solve the problems of high cost, no anti-tumor activity, and low selectivity, and achieve low cost, Strong selectivity and obvious anti-tumor activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] A kind of lysine derivative class histone deacetylase inhibitor: its general formula is:
[0024]
[0025] Its synthesis method is:
[0026] Synthesis scheme 1:
[0027] In the general formula (I), X is S or O or NH; Y is C; Z is S or O; R 1 is benzyloxycarbonyl, fluorenylmethoxycarbonyl; R 2 It is methoxy group and anilino group, and the specific synthetic route is:
[0028]
[0029] R 3 = H, CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH 2 (CH 2 ) 4 CH 3 , CH 2 (CH 2 ) 6 CH 3 , CH 2 (CH 2 ) 8 CH 3 , CH 2 (CH 2 ) 11 CH 3
[0030]
[0031] Synthesis scheme 2:
[0032] In the general formula (I), X is S or O or NH; Y is NH; Z is S or O; R 1 is benzyloxycarbonyl, fluorenylmethoxycarbonyl; R 2 It is methoxy group and anilino group; the specific synthetic route is:
[0033]
[0034] R 3 = H, CH 3 , CH 2 CH 3 , CH 2 CH 2 CH 3 , CH 2 (CH 2 ) 4 CH 3 , CH 2 (CH 2 ) 6 CH 3 , CH 2 (CH 2 ) 8 CH 3 , CH 2 (CH 2 ) 11 CH 3
[0...
experiment example 2
[0139] Concrete synthetic routes of compounds of general formula III
[0140]
[0141] Among them, the definition of R is shown in Table 2.
[0142] 1. The synthetic route of compound 21:
[0143]
[0144] The preparation of compound 21: take compound 4 (2g, 7.6mmol) with 10%Na 2 CO 3 Dissolve 15ml of the solution, add Fmoc-Cl (2.94g, 11.4mmol) dissolved in THF, react overnight at room temperature, adjust pH to 4-5 with 10% citric acid, remove THF under reduced pressure, add CH 2 Cl 2 Extraction, the organic phase was washed with a saturated NaCl solution, and dried under reduced pressure to obtain the product 21 (200mg, yield: 10%);
[0145] 1 H NMR (400MHz, DMSO-d) δ7.85(d, J=7.5Hz, 2H), 7.77~7.61(m, 3H), 7.37(t, J=7.5 Hz, 2H), 7.28(t, J= 7.4Hz, 2H), 4.32~4.14(m, 3H), 4.08(qd, J=8.8, 4.6Hz, 1H), 2.86(dt, J= 24.4, 10.2Hz, 1H), 2.70(ddd, J=15.2 ,9.6,5.6Hz,1H),2.55~2.41(m,2H),2.23(t,J=7.3Hz, 2H),1.68(dd,J=8.4,6.1Hz,2H),1.33(s,9H) .
[0146] 13 C-NMR (100MHz, DMS...
experiment example 3
[0264] activity screening
[0265] The existing Sirtuins subtypes are 1, 2, 3, 5, and 6, and the corresponding substrate polypeptides of 1, 2, and 3 subtypes are H3K9AcWW (200 μM) and its coenzyme NAD (1 mM); the substrate polypeptide of 5 H3K9SuWW ( 200 μM) and its coenzyme NAD (1 mM); the substrate polypeptide of 6 H3K9MyWW (200 μM) and its coenzyme NAD (1 mM).
[0266] 6.1 Sirt1, 2, 3 enzyme reaction
[0267]The substrate polypeptide H3K9AcWW (200 μM) and its coenzyme NAD (1 mM) were reacted with Sirt1, 2, 3 (1 μM) in Tris pH7.4 (20 mM) solution containing DTT (1 mM) at 37°C for 45 min, 10 min, and 30 min, respectively. In the positive group, the drug components to be tested were added during the reaction process, and the drug concentration was 100 μM for preliminary screening. Two negative control groups were set up, one group without adding screening drugs, and one group without adding Sirt1, 2, and 3 proteins. After reacting for 45min, 10min and 30min, all components ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com